INTERVIEW: Dr. Mark Sumeray Discusses Positive Phase 2a Data on AZP-3601 for Hypoparathyroidism (Pt. 1)
Photo courtesy of Amolyt Pharma

INTERVIEW: Dr. Mark Sumeray Discusses Positive Phase 2a Data on AZP-3601 for Hypoparathyroidism (Pt. 1)

When it comes to drug development and medical research, particularly within the rare disease sphere, it is incredibly important for patients to feel involved in the process. After all, patients…

Continue Reading INTERVIEW: Dr. Mark Sumeray Discusses Positive Phase 2a Data on AZP-3601 for Hypoparathyroidism (Pt. 1)
Newborn Screenings Miss Cystic Fibrosis in Non-White Newborns
https://pixabay.com/en/people-portrait-girl-black-girl-3194027/

Newborn Screenings Miss Cystic Fibrosis in Non-White Newborns

Newborn screening is a public health program in which infants are screened for various metabolic, genetic, and developmental disorders shortly after birth. Through newborn screening, doctors may identify potential disorders…

Continue Reading Newborn Screenings Miss Cystic Fibrosis in Non-White Newborns
IVIG Improved Dermatomyositis Symptoms, Study Says
Elizabeth M. Dugan, Adam M. Huber, Frederick W. Miller, Lisa G. Rider / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)

IVIG Improved Dermatomyositis Symptoms, Study Says

Currently, there are a number of therapies which can be used to treat individuals with dermatomyositis: corticosteroids, immunosuppressive agents, intravenous immune globulin (IVIG). Typically, corticosteroids are considered a first-line treatment,…

Continue Reading IVIG Improved Dermatomyositis Symptoms, Study Says
Grateful at Thanksgiving
source: pixabay.com

Grateful at Thanksgiving

There is a certain time of year in which the trees change color, the air becomes crisp and we pour gravy on everything. As I am typing this, I am…

Continue Reading Grateful at Thanksgiving
Science Simplified: What Are Genetic Mouse Models and How Can They Help Us Study Genetic Diseases And Develop Treatments?
source: pixabay.com

Science Simplified: What Are Genetic Mouse Models and How Can They Help Us Study Genetic Diseases And Develop Treatments?

Want to learn about scientific topics without needing a PhD? Check out the Science Simplified blog from TESS Research Foundation! Dr. Tanya Brown, PhD, works with researchers to make science…

Continue Reading Science Simplified: What Are Genetic Mouse Models and How Can They Help Us Study Genetic Diseases And Develop Treatments?
INTERVIEW: Mirum’s Chris Peetz Discusses Positive Topline Data on LIVMARLI for PFIC (Pt. 2)
Photo courtesy of Mirum

INTERVIEW: Mirum’s Chris Peetz Discusses Positive Topline Data on LIVMARLI for PFIC (Pt. 2)

Before you read on, make sure to check out Part 1 of our interview. In Part 1, Chris Peetz discusses his background, why he joined Mirum, and the process of evaluating LIVMARLI…

Continue Reading INTERVIEW: Mirum’s Chris Peetz Discusses Positive Topline Data on LIVMARLI for PFIC (Pt. 2)

Raising Awareness of Recessive Dystrophic Epidermolysis Bullosa: Patterson’s Story (Pt. 2)

Before you read on, make sure to check out Part 1 of our interview, where Annie, Peter, and Patterson discuss what recessive dystrophic epidermolysis bullosa (RDEB) is, Patterson's diagnostic journey, and how…

Continue Reading Raising Awareness of Recessive Dystrophic Epidermolysis Bullosa: Patterson’s Story (Pt. 2)
Serdexmethylphenidate for Idiopathic Hypersomnia Earns Orphan Drug Designation
https://pixabay.com/en/toddler-boy-sleeping-child-1245674/

Serdexmethylphenidate for Idiopathic Hypersomnia Earns Orphan Drug Designation

  In the United States, the FDA grants Orphan Drug designation to drugs or biologics intended to treat, diagnose, or prevent rare diseases or conditions. A rare disease is one…

Continue Reading Serdexmethylphenidate for Idiopathic Hypersomnia Earns Orphan Drug Designation
INTERVIEW: Mirum’s Chris Peetz Discusses Positive Topline Data on LIVMARLI for PFIC (Pt. 1)
Photo courtesy of Mirum

INTERVIEW: Mirum’s Chris Peetz Discusses Positive Topline Data on LIVMARLI for PFIC (Pt. 1)

The American Association for the Study of Liver Disease (AASLD) held its annual Liver Meeting from November 4-7, 2022 in Washington, D.C. During the meeting, Mirum Pharmaceuticals shared two late-breaker…

Continue Reading INTERVIEW: Mirum’s Chris Peetz Discusses Positive Topline Data on LIVMARLI for PFIC (Pt. 1)